Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Recruiting NCT07845942

Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.

Conditions: Refractory Systemic Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis Associated Lung Disease

Sex: All

Ages: N/A – 35 Years

Healthy volunteers: No

Enrollment: 20

Sponsor: Children's Hospital Medical Center, Cincinnati

Location: Cincinnati Children's Hospital Medical Center Cincinnati Ohio

Summary

The goal of this study is to collect clinical data and samples and to evaluate the feasibility of allogeneic hematopoietic cell transplantation (HCT) in children and young adults with refractory Systemic Juvenile Idiopathic Arthritis (sJIA), including those with sJIA-associated lung disease (sJIA-LD).

Eligibility Criteria

Inclusion Criteria: * Patients \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07845942). StuddyBuddy aggregates publicly available trial information.